col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


31 Ergebisse       Seite 1

 [1] 
SAGE Publications: Journal of Oncology Pharmacy Practice
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Mrz―08 Pharmacist's role in the management of drug-drug interactions caused by nirmatrelvir/ritonavir in COVID-19 oncohematology patients Carlos Guzmán Cordero, María Sáez-Torres de Vicente, Álvaro Jiménez Espinosa, Ana Isabel Gago Sánchez
2 [GO] 2022―Jan―11 Impact of the COVID-19 pandemic on new starts to oral oncology medications in the US Lynn Neilson, Monal Kohli, Kiraat D Munshi, Samuel K Peasah, Rochelle Henderson, Vida Passero, Chester B Good
3 [GO] 2021―Dez―14 The experience of cancer patients during the COVID-19 pandemic Melanie Dalby, Nikant Ailawadi
4 [GO] 2021―Okt―23 Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners Grace Chazan, Jennifer Jupp, Tiene Bauters, Nick Duncan, Kellie Jones Weddle, Hisanaga Nomura, et al. (+19)
5 [GO] 2021―Okt―13 Potential interactions between antineoplastic agents and medicines used to treat Covid-19 Mario Jorge Sobreira da Silva, Claudia Garcia Serpa Osorio-de-Castro, Rafael Duarte Paes, Christopher Lucas Negrete, Elizangela Eugênio, Elaine Lazzaroni Moraes, Annemeri Livinalli
6 [GO] 2021―Sep―30 Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards Deniz C Guven, Imdat Eroglu, Rashad Ismayilov, Ege Ulusoydan, Oktay H Aktepe, Gulcin Telli Dizman, et al. (+5)
7 [GO] 2021―Sep―25 Acceptance of coronavirus disease 2019 vaccination by cancer patients in Cyprus: A cross-sectional study Zoe Roupa, Maria Noula, Monica Nikitara, Savoula Ghobrial, Evangelos Latzourakis, Giannis Polychronis
8 [GO] 2021―Aug―23 Alectinib, COVID-19 and favipiravir Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
9 [GO] 2021―Mai―13 Global changes to the chemotherapy service during the covid-19 pandemic Man-Chie Chow, Pinkie Chambers, Georgina Singleton, Jignesh Patel, Silvie Cooper, Charlotte Mythen, et al. (+6)
10 [GO] 2021―Mai―09 Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? Murat Ayhan, Şahin Laçin, Deniz T Özyükseler, Heves Sürmeli, Akif Doğan, Merve Turan, et al. (+3)
11 [GO] 2021―Apr―24 Immune-checkpoint inhibitor toxicity during a pandemic: Overcoming patient fears to provide care. A case report Christopher T Elder, Elizabeth C Davis, Stephanie Jaipal, Charles E Wight
12 [GO] 2021―Feb―11 Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic Maria Marchese, Angela Heintzman, Mark Pasetka, Flay Charbonneau, Carlo DeAngelis, Christine Peragine
13 [GO] 2021―Jan―28 Cancer patient experience of telephone clinics implemented in light of COVID-19 Melanie Dalby, Alison Hill, Shereen Nabhani-Gebara
14 [GO] 2021―Jan―20 Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle? Emre Yekedüz, Güngör Utkan, Yüksel Ürün
15 [GO] 2021―Jan―18 Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City Prakirthi Yerram, Jennifer Thackray, Lisa R Modelevsky, Josiah D Land, Samantha N Reiss, Krisoula H Spatz, et al. (+18)
16 [GO] 2020―Nov―02 Coping with the residency program during COVID-19: Hematology oncology pharmacy residents’ perspective Aeshah A AlAzmi, Fouad AlNajjar, Majed AlShomrani
17 [GO] 2020―Okt―23 Response of an oncology unit in the midst of the COVID-19 outbreak Michalis Liontos, Efstathios Kastritis, Magdalini Migkou, Konstantinos Koutsoukos, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, et al. (+4)
18 [GO] 2020―Okt―21 Tyrosine kinase inhibitors and COVID-19 Başcı Semih, Yiğenoğlu Tuğçe Nur, Dal Mehmet Sinan, Korkmaz Serdal, Turgut Burhan, Altuntaş Fevzi
19 [GO] 2020―Okt―21 Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors Banu Cakir
20 [GO] 2020―Okt―08 Optimizing the role of ambulatory chemotherapy in response to the Covid-19 pandemic Racha Sabbagh Dit Hawasli, Shereen Nabhani-Gebara
21 [GO] 2020―Sep―29 A practical approach to the management of colorectal cancer during the COVID-19 crisis in the reference cancer treatment center in Tunisia Feriel Letaief, Imen Gharbi, Adel Hamdi, Yosra Yahyaoui, Mona Ayadi, Imen Blousa, Amel Mezlini
22 [GO] 2020―Sep―25 Clinical strategies for optimizing infusion center care through a pandemic Kirollos S Hanna, Eve M Segal, Ashley Barlow, Brooke Barlow
23 [GO] 2020―Aug―28 Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors Semih Başcı, Naim Ata, Fevzi Altuntaş, Tuğçe Nur Yiğenoğlu, Mehmet Sinan Dal, Serdal Korkmaz, et al. (+13)
24 [GO] 2020―Aug―14 Switch in use of midazolam for cancer patients during the COVID-19 pandemic Guillaume Marliot, Nicolas Penel, Vincent Gamblin
25 [GO] 2020―Aug―14 Suggestion of Tunisia’s medical oncologist in the management of breast cancer during COVID-19 pandemic Yosra Yahyaoui, Zahra Ghodhbani, Adel Hamdi, Feryel Letaief, Yosr Zenzri, Azza Ben Said, et al. (+2)
26 [GO] 2020―Jul―06 Are we aware of potential interactions between drugs used in lung cancer and drugs used in the treatment of COVID-19? Elif Aras-Atik, Kamer Tecen-Yucel, Aygin Bayraktar-Ekincioglu
27 [GO] 2020―Jun―25 Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations Majed Alshamrani, Atika AlHarbi, Nora Alkhudair, Fouad AlNajjar, Mansoor Khan, Abdulaziz Ben Obaid, et al. (+6)
28 [GO] 2020―Jun―07 Routine antiemetic prophylaxis with dexamethasone during COVID-19: Should oncologists reconsider? Mark A Marinella
29 [GO] 2020―Mai―29 Use of personal protective equipment while admixing antineoplastic drugs during the COVID-19 pandemic era: Questionnaire survey in Niigata, Japan Satoru Mitsuboshi, Masaki Yoshino, Hiroki Hosokawa, Hirokazu Isobe, Kenichi Kobayashi
30 [GO] 2020―Mai―19 Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab Emre Yekedüz, Bengü Dursun, Güle Ç Aydın, Satı C Yazgan, Halis H Öztürk, Alpay Azap, et al. (+2)
31 [GO] 2020―Mai―15 Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety Marliese Alexander, Jennifer Jupp, Grace Chazan, Shaun O’Connor, Alexandre Chan
 [1] 

31 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.014 sec